http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H0248525-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a452aeb7f766d55db6921d784361b891 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_eebd94dd108d74a49ab9415252e5e281 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-355 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-352 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-38 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D311-72 |
| filingDate | 1988-08-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7b2f101756723925ed30f85fa6f7c056 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5fdaea329820fcc6b701a644c2e20ffd http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e83700ecb81fbedad5c6a007b6352461 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f396f3f2e9ed4858482cbf5dc312e7c6 |
| publicationDate | 1990-02-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-H0248525-A |
| titleOfInvention | Remedy for peptic ulcer |
| abstract | PURPOSE: To provide a remedy for peptic ulcer containing tocopheryl retinoate and high-viscosity hydroxypropyl cellulose, covering the digestive mucosa with the remedy by oral administration and capable of selectively keeping the active component to the ulcer site over a long period. n CONSTITUTION: The objective agent can be prepared by compounding (A) a drug preparation containing tocopheryl retinoate (an α-tocopherol vitamin A acid ester) as an active component with (B) 2-50wt.%, preferably 20-30wt.% (based on the whole agent) of a high-viscosity hydroxypropyl cellulose preferably having a viscosity of 1,000-10,000 cps, especially 4,000-6,500 cps as 2% aqueous solution at 25°C. The obtained drug exhibits the attaching and retaining effect on the gastric mucosa, keeps high concentration of the active component on the ulcer site and is expected to have improved utilization ratio based on the administered dose. The administration dose and period can be decreased compared with conventional remedy. n COPYRIGHT: (C)1990,JPO&Japio |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0389982-A2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0002554-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2015020964-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2013010713-A |
| priorityDate | 1988-08-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 31.